![]() Biosearch Life Biosearch Life is a biotechnology company that provides probiotics, omega-3 fatty acids, and botanical extracts. | ![]() Momenta Pharmaceuticals Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. | ![]() Cue Biopharma Cue Biopharma is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease. | Kuros Biosciences Kuros Biosciences is a biopharmaceutical company that engages in the development of biopharmaceutical products for tissue repair and bone regeneration. | ![]() Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. | |
Founding Date | Founding Date 2000 | Founding Date 2001 | Founding Date 2015 | Founding Date 2000 | Founding Date 2005 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Granada, ES HQ Madrid, ES | Locations Cambridge, US HQ Dublin, IE Cambridge, US | Locations Cambridge, US HQ | Locations Zürich, CH HQ Bilthoven, NL Boston, US | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US |
Employees | Employees 140 | Employees 77 | Employees 4664% increase | Employees 12215% increase | Employees 3808% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 107.3 m | Valuation ($) N/A | Valuation ($) 722.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $23.9m (FY, 2019) | Revenue (est.) $9.3m (FY, 2024) | Revenue (est.) CHF75.6m (FY, 2024) | Revenue (est.) $194.1m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods CHF6.4m (FY, 2024) | Cost of goods $26.8m (FY, 2021) |
Net income | Net income N/A | Net income ($290.1m) (FY, 2019) | Net income ($40.7m) (FY, 2024) | Net income (CHF3.7m) (FY, 2024) | Net income ($74.8m) (FY, 2021) |
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules.
View companyCue Biopharma is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease.
View companyKuros Biosciences is a biopharmaceutical company that engages in the development of biopharmaceutical products for tissue repair and bone regeneration.
View companyAerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company